1. Home
  2. CMMB vs MYND Comparison

CMMB vs MYND Comparison

Compare CMMB & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

HOLD

Current Price

$2.85

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Logo Mynd.ai Inc.

MYND

Mynd.ai Inc.

HOLD

Current Price

$0.39

Market Cap

19.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMMB
MYND
Founded
2004
1998
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
19.9M
19.2M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
CMMB
MYND
Price
$2.85
$0.39
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
98.2K
43.7K
Earning Date
05-21-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
101.67
N/A
EPS
0.04
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$67.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$0.28
52 Week High
$3.55
$1.15

Technical Indicators

Market Signals
Indicator
CMMB
MYND
Relative Strength Index (RSI) 84.13 49.54
Support Level $1.47 $0.30
Resistance Level $2.86 $0.49
Average True Range (ATR) 0.21 0.07
MACD 0.06 -0.00
Stochastic Oscillator 87.54 27.97

Price Performance

Historical Comparison
CMMB
MYND

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

About MYND Mynd.ai Inc.

Mynd.ai Inc provides world'wide, end-to-end, learning solutions and collaboration tools to help teachers, schools, students, and professionals realize their greatest potential. The company has single reporting segment. The company has presence in United States and Rest of world. The company generates majority of revenue from United States.

Share on Social Networks: